GlassScriptPhysician profile
David Weintraub
NPI 1417191750
$11,268.53
in general payments reported to CMS, 2019-2025
9 companies · $334 in 2025
The $334 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,955 · 2020: $1,784 · 2021: $2,496 · 2022: $1,123 · 2023: $127 · 2024: $450 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $867 · Travel and Lodging: $44.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $866.74 |
| Travel and Lodging | $44.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,988.90 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Nevro Corp. | $3,076.07 | 2020-2023 | Senza |
| Abbott Laboratories | $1,606.63 | 2019-2022 | |
| Medtronic, INC. | $918.91 | 2021-2025 | Prestige LP Cervical Disc System, Anteralign Spinal System With Titan Nanolock Surface Technology |
| Si-Bone, INC. | $449.20 | 2024-2025 | |
| Vertos Medical, INC. | $167.79 | 2022 | |
| Depuy Synthes Sales INC. | $33.08 | 2022 | |
| Stryker Corporation | $18.61 | 2022 | |
| Relievant Medsystems, INC. | $9.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Weintraub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.